LOS ANGELES, CA--(Marketwire - Nov 13, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) CEO Robert H. Lorsch is attending the Verizon and Alcatel-Lucent Annual Healthcare and Life Science Symposium in Las Vegas today. The event specifically addresses advancements in wireless technology for the healthcare industry which is a primary focus of MMR (http://hcls.vzwtechnologies.com). The Company has been invited by Alcatel-Lucent to participate in discussions regarding the sale and licensing of its patented Personal Health Record (PHR), which includes a telemedicine portal for use by hospitals, physicians, carriers, payers, and other healthcare professionals. MMR currently holds four U.S. patents with more than 180 claims for health IT products and services and also has patents that are issued, pending and/or applied for in more than 13 countries of commercial interest around the world.
Using the Verizon and Alcatel-Lucent mobile healthcare platforms and services for telemedicine, the MyMedicalRecords.com patented Personal Health Record can help physicians, caretakers and family members better monitor patients. "I have had a long relationship with Verizon Wireless, going back to the early days of AirTouch," said Lorsch. "We also hold a significant patent portfolio pertaining to Personal Health Records and other eHealth products and services that create both a barrier to competitive entry and generating revenue to the Company from licensing activities."
The re-election of President Obama means healthcare reform is here to stay. This benefits companies like MMRGlobal that enable patients to have timely online access to their personal health information as mandated through Meaningful Use under the HITECH Act by 2014. And with tens of millions of U.S. citizens becoming newly insured under the Affordable Care Act, and therefore consumers of healthcare, greater patient engagement will be essential to manage care and costs by providing patients with a PHR.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.
Statements in this press release that are not strictly historical in nature, including future performance, expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMRGlobal, Inc.'s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk our products and services are not adopted or viewed favorably by consumers and the healthcare community, both in the U.S. and internationally; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally product integration in physician practices and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations including the HITECH Act of 2009 and the Affordable Care Act of 2010, and future changes in tax legislation and initiatives in the healthcare industry, both in the U.S. and internationally; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; litigation matters; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the United States Securities and Exchange Commission. MMRGlobal, Inc. is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.